{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:14:11Z","timestamp":1773382451900,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Redes Tem\u00e1ticas de Investigaci\u00f3n Cooperativa, Red de Trastornos Adictivos RD12\/0028\/0012 & RD16\/0017\/0006, co-funded by FEDER funds of the European Union \u2013a way to build Europe."],"award-info":[{"award-number":["Redes Tem\u00e1ticas de Investigaci\u00f3n Cooperativa, Red de Trastornos Adictivos RD12\/0028\/0012 & RD16\/0017\/0006, co-funded by FEDER funds of the European Union \u2013a way to build Europe."]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13011-017-0108-3","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:10:14Z","timestamp":1494375014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain"],"prefix":"10.1186","volume":"12","author":[{"given":"Inmaculada","family":"Fierro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Col\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Gonz\u00e1lez-Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5678","authenticated-orcid":false,"given":"F. Javier","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"108_CR1","volume-title":"Final report: work performed, main results and recommendations. Driving under the influence of drugs, alcohol and medicines in Europe \u2014 findings from the DRUID project. Publications Office of the European Union","author":"H Schulze","year":"2012","unstructured":"Schulze H, Schumacher M, Urmeew R, Auerbach K, Alvarez FJ, Bernhoft IM, de Gier H, Hagenzieker M, Houwing S, Knoche A, Pilgerstorfer M, Zlender B. Final report: work performed, main results and recommendations. Driving under the influence of drugs, alcohol and medicines in Europe \u2014 findings from the DRUID project. Publications Office of the European Union. Luxembourg: EMCDDA; 2012. \nhttp:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_192773_EN_TDXA12006ENN.pdf\n\n. Accessed 9 Jan 2017"},{"key":"108_CR2","volume-title":"Final report: work performed, main results and recommendations. Revisi\u00f3n 2.0","author":"DRUID","year":"2012","unstructured":"DRUID. Final report: work performed, main results and recommendations. Revisi\u00f3n 2.0. Cologne: BAST; 2012. \nhttp:\/\/www.druid-project.eu\/Druid\/EN\/Dissemination\/downloads_and_links\/Final_Report.html?nn=613800\n\n. Accessed 9 Jan 2017"},{"key":"108_CR3","volume-title":"Drug use and road safety: a policy brief","author":"WHO","year":"2016","unstructured":"WHO. Drug use and road safety: a policy brief. Geneva: World Health Organization; 2016. WHO reference number: WHO\/MSD\/MSB16.01. \nhttp:\/\/apps.who.int\/iris\/bitstream\/10665\/249533\/1\/WHO-MSD-NVI-2016.01-eng.pdf?ua=1\n\n. Accessed 9 Jan 2017"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.20882\/adicciones.702","volume":"27","author":"FJ \u00c1lvarez","year":"2015","unstructured":"\u00c1lvarez FJ, Gonz\u00e1lez-Luque JC, Segu\u00ed-G\u00f3mez M. Drugs, substance use disorder and driving: intervention of health professionals in the treatment of addictions. Adicciones. 2015;27:161\u20137.","journal-title":"Adicciones"},{"key":"108_CR5","unstructured":"GOV:UK. Drugs and driving: the law. Collection Drug driving. \nhttps:\/\/www.gov.uk\/drug-driving-law\n\n \nhttps:\/\/www.gov.uk\/government\/collections\/drug-driving#table-of-drugs-and-limits\n\n. Accessed 9 Jan 2017."},{"key":"108_CR6","volume-title":"Driving under the influence of non-alcohol drugs \u2013 legal limits implemented in Norway","author":"Norwegian Ministry of Transport and Communications","year":"2014","unstructured":"Norwegian Ministry of Transport and Communications. Driving under the influence of non-alcohol drugs \u2013 legal limits implemented in Norway. Oslo: Norwegian Government Security and Service Organization; 2014. \nhttps:\/\/www.regjeringen.no\/globalassets\/upload\/sd\/vedlegg\/brosjyrer\/sd_ruspavirket_kjoring_net.pdf\n\n. Accessed 9 Jan 2017"},{"key":"108_CR7","doi-asserted-by":"crossref","unstructured":"Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int 2005;150:143-50.","DOI":"10.1016\/j.forsciint.2004.11.023"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jat\/bkt122","volume":"38","author":"H Gjerde","year":"2014","unstructured":"Gjerde H, Langel K, Favretto D, Verstraete AG. Estimation of equivalent cutoff thresholds in blood and oral fluid for drug prevalence studies. J Anal Toxicol. 2014;38:92\u20138.","journal-title":"J Anal Toxicol"},{"key":"108_CR9","volume-title":"Guidance for healthcare professionals on drug driving","author":"Department for Transport","year":"2014","unstructured":"Department for Transport. Guidance for healthcare professionals on drug driving. London: Department for Transport; 2014. \nhttps:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/325275\/healthcare-profs-drug-driving.pdf\n\n. Accessed 9 Jan 2017"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.forsciint.2012.08.012","volume":"30","author":"T G\u00f3mez-Taleg\u00f3n","year":"2012","unstructured":"G\u00f3mez-Taleg\u00f3n T, Fierro I, Gonz\u00e1lez-Luque JC, Col\u00e1s M, L\u00f3pez-Rivadulla M, \u00c1lvarez FJ. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study. Forensic Sci Int. 2012;30:106\u201313.","journal-title":"Forensic Sci Int"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.drugpo.2015.04.021","volume":"26","author":"I Fierro","year":"2015","unstructured":"Fierro I, Gonz\u00e1lez-Luque JC, Segu\u00ed-G\u00f3mez M, \u00c1lvarez FJ. 2015. Alcohol and drug use by Spanish drivers: comparison of two cross-sectional road-side surveys (2008-9\/2013). Int J Drug Policy. 2015;26:794\u20137.","journal-title":"Int J Drug Policy"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00216-008-2135-4","volume":"391","author":"M Concheiro","year":"2008","unstructured":"Concheiro M, de Castro A, Quintela O, Cruz M, L\u00f3pez-Rivadulla M. Determination of illicit and medical drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008;391:2329\u201338.","journal-title":"Anal Bioanal Chem"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2014.09.770","volume":"144","author":"I Fierro","year":"2014","unstructured":"Fierro I, Gonz\u00e1lez-Luque JC, Alvarez FJ. The relationship between observed signs of impairment and THC concentration in oral fluid. Drug Alcohol Depend. 2014;144:231\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2125.2012.04279.x","volume":"74","author":"S Ravera","year":"2012","unstructured":"Ravera S, Monteiro S, de Gier JJ, van der Linden T, G\u00f3mez-Taleg\u00f3n T, \u00c1lvarez F. J. & the DRUID project WP4 partner. A European approach to categorising medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol. 2012;74:920\u201331.","journal-title":"Br J Clin Pharmacol"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2010.05.012","volume":"150","author":"SE Kendall","year":"2010","unstructured":"Kendall SE, Sj\u00f8gren P, de Pimenta CAM, H\u00f8jsted J, Kurita GP. The cognitive effects of opioids in chronic non-cancer pain. Pain. 2010;150:225\u201330.","journal-title":"Pain"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/AJP.0b013e3182385332","volume":"28","author":"A Mailis-Gagnon","year":"2012","unstructured":"Mailis-Gagnon A, Lakha SF, Furlan A, Nicholson K, Yegneswaran B, Sabatowski R. Systematic review of the quality and generalizability of studies on the effects of opioids on driving and cognitive\/psychomotor performance. Clin J Pain. 2012;28:542\u201355.","journal-title":"Clin J Pain"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00213-017-4539-3","volume":"234","author":"MB Schumacher","year":"2017","unstructured":"Schumacher MB, Jongen S, Knoche A, Petzke F, Vuurman EF, Vollrath M, Ramaekers JG. Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients. Psychopharmacology. 2017;234:989\u201399.","journal-title":"Psychopharmacology"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6904-11-13","volume":"11","author":"P Rapeli","year":"2011","unstructured":"Rapeli P, Fabritius C, Kalska H, Alho H. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol. 2011;11:13.","journal-title":"BMC Clin Pharmacol"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15389588.2012.689451","volume":"14","author":"MC Strand","year":"2013","unstructured":"Strand MC, Fjeld B, Arnestad M, M\u00f8rland J. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration. Traffic Inj Prev. 2013;14:26\u201338.","journal-title":"Traffic Inj Prev"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.01.017","volume":"117","author":"S Shmygalev","year":"2011","unstructured":"Shmygalev S, Damm M, Weckbecker K, Berghaus G, Petzke F, Sabatowski R. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function. Drug Alcohol Depend. 2011;117:190\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2011.10.022","volume":"123","author":"P Corsenac","year":"2012","unstructured":"Corsenac P, Lagarde E, Gadegbeku B, Delorme B, Tricotel A, Castot A, Moore N, Philip P, Laumon B, Orriols L. Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study. Drug Alcohol Depend. 2012;123:91\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1360-0443.2011.03745.x","volume":"107","author":"JG Bramness","year":"2012","unstructured":"Bramness JG, Skurtveit S, M\u00f8rland J, Engeland A. An increased risk of motor vehicle accidents after prescription of methadone. Addiction. 2012;107:967\u201372.","journal-title":"Addiction"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.aap.2012.06.017","volume":"60","author":"R Elvik","year":"2013","unstructured":"Elvik R. 2013. Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev. 2013;60:254\u201367.","journal-title":"Accid Anal Prev."},{"key":"108_CR24","doi-asserted-by":"crossref","unstructured":"Kuypers KP, Legrand SA, Ramaekers JG, Verstraete AG. 2012. A case-control study estimating accident risk for alcohol, medicines and illegal drugs. PLoS ONE. 2012;7:e43496.","DOI":"10.1371\/journal.pone.0043496"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.aap.2016.08.001","volume":"96","author":"TM Rudisill","year":"2016","unstructured":"Rudisill TM, Zhu M, Kelley GA, Pilkerton C, Rudisill BR. Medication use and the risk of motor vehicle collisions among licensed drivers: a systematic review. Accid Anal Prev. 2016;96:255\u201370.","journal-title":"Accid Anal Prev"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1747-597X-8-19","volume":"8","author":"C Roncero","year":"2013","unstructured":"Roncero C, \u00c1lvarez FJ, Barral C, G\u00f3mez-Baeza S, Gonzalvo B, Rodr\u00edguez-Cintas L, Brugal MT, Jacas C, Romaguera A, Casas M. PROTEUS study investigators. Driving and legal status of Spanish opioid-dependent patients. Subst Abuse Treat Prev Policy. 2013;8:19.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"108_CR27","first-page":"7","volume":"47","author":"M Soyka","year":"2014","unstructured":"Soyka M. Opioids and traffic safety \u2013 focus on Buprenorphine. Pharmacopsychiatry. 2014;47:7\u201317.","journal-title":"Pharmacopsychiatry"},{"key":"108_CR28","unstructured":"NIDA. Topics in brief. Prescription Drug Abuse \u2013 December 2011. \nhttps:\/\/www.drugabuse.gov\/sites\/default\/files\/prescription_1.pdf\n\n. Accessed 9 Jan 2017."},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jat\/bks037","volume":"36","author":"GM Reisfield","year":"2012","unstructured":"Reisfield GM, Goldberger BA, Gold MS, DuPont RL. The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws. J Anal Toxicol. 2012;36:353\u20136.","journal-title":"J Anal Toxicol"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40621-014-0026-z","volume":"1","author":"K Wong","year":"2014","unstructured":"Wong K, Brady JE, Li G. Establishing legal limits for driving under the influence of marijuana. Inj Epidemiol. 2014;1:26.","journal-title":"Inj Epidemiol"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/dta.1588","volume":"6","author":"K Wolff","year":"2014","unstructured":"Wolff K, Johnston A. Cannabis use: a perspective in relation to the proposed UK drug-driving legislation. Drug Test Anal. 2014;6:143\u201354.","journal-title":"Drug Test Anal"},{"key":"108_CR32","unstructured":"EMCDDA. Legal approaches to drugs and driving. \nhttp:\/\/www.emcdda.europa.eu\/html.cfm\/index19034EN.html\n\n. Accessed 9 Jan 2017."}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-017-0108-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:10:33Z","timestamp":1494375033000},"score":1,"resource":{"primary":{"URL":"http:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-017-0108-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1186\/s13011-017-0108-3","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]},"article-number":"22"}}